Gastrointestinal microbiota-directed nutritional and therapeutic interventions for inflammatory bowel disease: opportunities and challenges
Gastroenterology Report · 22.12.2023 · 12
DOI: 10.1093/gastro/goae033 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Gastroenterology Report, online erschienen am 27.04.2024. Verfasst von Devendra Paudel und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nutritional Sciences, The Pennsylvania State University, University Park, PA, USA. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, Career Development, Crohn’s and Colitis Foundation, National Institutes of Health.
Abstract (Originalsprache)
Evidence-based research has confirmed the role of gastrointestinal microbiota in regulating intestinal inflammation. These data have generated interest in developing microbiota-based therapies for the prevention and management of inflammatory bowel disease (IBD). Despite in-depth understanding of the etiology of IBD, it currently lacks a cure and requires ongoing management. Accumulating data suggest that an aberrant gastrointestinal microbiome, often referred to as dysbiosis, is a significant environmental instigator of IBD. Novel microbiome-targeted interventions including prebiotics, probiotics, fecal microbiota transplant, and small molecule microbiome modulators are being evaluated as therapeutic interventions to attenuate intestinal inflammation by restoring a healthy microbiota composition and function. In this review, the effectiveness and challenges of microbiome-centered interventions that have the potential to alleviate intestinal inflammation and improve clinical outcomes of IBD are explored.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Nutritional Sciences, The Pennsylvania State University, University Park, PA, USA.
- Department of Pharmaceutical Sciences and Medicines, Faculty of Pharmacy, Universidade de Lisboa, Lisboa, Portugal.
- College of Pharmacy, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
Förderung
- NIDDK NIH HHS
- Career Development
- Crohn’s and Colitis Foundation, National Institutes of Health
Zitieren
APA
Paudel, D., Nair, D. V. T., Joseph, G., Castro, R., Tiwari, A. K., & Singh, V. (2023). Gastrointestinal microbiota-directed nutritional and therapeutic interventions for inflammatory bowel disease: opportunities and challenges. Gastroenterology Report, 12. https://doi.org/10.1093/gastro/goae033
Vancouver
Paudel D, Nair DVT, Joseph G, Castro R, Tiwari AK, Singh V. Gastrointestinal microbiota-directed nutritional and therapeutic interventions for inflammatory bowel disease: opportunities and challenges. Gastroenterology Report. 2023;12. doi:10.1093/gastro/goae033
BibTeX
@article{Paudel2023,
author = {Paudel, Devendra and Nair, Divek V T and Joseph, Grace and Castro, Rita and Tiwari, Amit K and Singh, Vishal},
title = {Gastrointestinal microbiota-directed nutritional and therapeutic interventions for inflammatory bowel disease: opportunities and challenges},
journal = {Gastroenterology Report},
year = {2023},
volume = {12},
doi = {10.1093/gastro/goae033}
}
EUVIMED